Are male eggs and female sperm on the horizon?
By Peter Aldhous,
New Scientist
| 02. 02. 2008
[Quotes CGS's Marcy Darnovsky]
"FEMALE sperm", "male eggs" and "same-sex reproduction" - whether these terms fill you with hope or disgust, a reproductive revolution is already in progress. In a handful of labs across the world, biologists are trying to make genetically male cells develop into eggs, and female cells into sperm. If successful, their efforts might one day allow lesbian and gay couples to have children that are genetically their own.
Now Greg Aharonian, a patent analyst from San Francisco, is trying to patent the technologies that could make this possible. In part, Aharonian's goal is to stimulate debate. He argues that lesbians and gay men have a right to know about developments in biology that could allow same-sex reproduction. Aharonian also wants to undermine the argument that marriage should remain an exclusively heterosexual institution because its main purpose is procreation. "I'm a troublemaker," he admits.
In the US, where reproductive clinics are largely unregulated and religious conservatives are at war with gay rights campaigners over same-sex marriage, it should indeed cause controversy. Same-sex reproduction is also an issue in the UK, where...
Related Articles
By Priyanka Runwal, Chemical and Engineering News | 08.05.2024
Saritee Sanodiya, 26, has spent countless days wondering if she’ll ever live a “normal” life. Growing up, Sanodiya often missed school, frequenting the hospital for sudden, life-threatening drops in her hemoglobin levels and excruciating pain in her joints. High fever...
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...
By Sarah Kliff and Azeen Ghorayshi, The New York Times | 07.15.2024